41 completed, 8 terminated, 2 active not recruiting, 2 not yet recruiting. 58 Phase 1, 8 Phase 2.
Follow Cranial Nerve Neoplasms: new trials by email Literature Review of Cranial Nerve Neoplasms trials Research Report on Cranial Nerve Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Luvometinib in Combination With Serplulimab for NF2-Related Tumors Luvometinib, Serplulimab - NF2-related Schwannomatosis, NF2 | Phase 1 / Phase 2 | Not yet recruiting | Beijing Tiantan Hospital | 30 | 2026-07-31 | 2026-07-16 |
| Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients With Neurofibromatosis Type II Trineumin - Neurofibromatosis Type II, NF2 | Phase 1 / Phase 2 | Not yet recruiting | PRG Science & Technology Co., Ltd. | 25 | 2026-07-01 | 2026-01-23 |
| Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma AAVAnc80-antiVEGF via Akouos Delivery Device - Vestibular Schwannoma | Phase 1 / Phase 2 | Recruiting | Eli Lilly and Company | 27 | 2025-01-17 | 2026-11-04 |
| Doxycycline in Cutaneous Schwannoma (NF2) Doxycycline Injection [Doxy] - Neurofibromatosis Type 2 | Phase 1 / Phase 2 | Active not recruiting | Massachusetts Eye and Ear Infirmary | 19 | 2022-09-19 | 2026-10-16 |
| Triamcinolone Levels in Cochlear Perilymph, Lateral Canal and CSF Triamcinolone Acetonide 40mg/mL - Vestibular Schwannoma | Phase 1 | Completed | Medical University of Vienna | 21 | 2020-02-01 | 2022-08-24 |
| Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours Selumetinib - Neurofibromatosis Type 1, Plexiform Neurofibroma | Phase 1 / Phase 2 | Completed | Great Ormond Street Hospital for Children NHS Foundation Trust | 14 | 2019-09-26 | 2024-04-04 |
| Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors Laboratory Biomarker Analysis, Pharmacological Study, Pomalidomide - Neurofibromatosis Type 1, Recurrent Childhood Brain Stem Glioma | Phase 1 | Completed | National Cancer Institute (NCI) | 29 | 2015-07-14 | 2022-04-25 |
| A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas Mebendazole, Vincristine, Carboplatin - Pilomyxoid Astrocytoma, Pilocytic Astrocytoma | Phase 1 / Phase 2 | Active not recruiting | Julie Krystal | 10 | 2013-10-22 | 2026-08-06 |
| Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors Photofrin (porfimer sodium) & photodynamic therapy. - Brain Tumor, Recurrent | Phase 1 | Completed | Harry T Whelan, MD | 5 | 2013-03-01 | 2019-02-25 |
| Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease Bevacizumab, Cetuximab, Laboratory Biomarker Analysis - Advanced Malignant Neoplasm, Castleman Disease | Phase 1 | Terminated | M.D. Anderson Cancer Center | 116 | 2012-10-16 | 2026-11-05 |
| Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma Bevacizumab (Avastin) - Vestibular Schwannoma | Phase 1 | Suspended | Northwell Health | 30 | 2011-08-01 | 2026-06-01 |
| Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma imetelstat sodium, laboratory biomarker analysis, pharmacological study - Brain and Central Nervous System Tumors, Lymphoma | Phase 1 | Completed | Children's Oncology Group | 34 | 2011-05-01 | 2014-01-30 |
| PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors VEGF inhibitor PTC299 - Brain and Central Nervous System Tumors | Phase 1 | Completed | Pediatric Brain Tumor Consortium | 28 | 2010-11-01 | 2015-05-04 |
| RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma 3-Dimensional Conformal Radiation Therapy, Gamma-Secretase Inhibitor RO4929097, Intensity-Modulated Radiation Therapy - Acoustic Schwannoma, Adult Anaplastic (Malignant) Meningioma | Phase 1 | Completed | National Cancer Institute (NCI) | 22 | 2010-05-01 | 2015-09-29 |
| Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia gamma-secretase/Notch signalling pathway inhibitor RO4929097, diagnostic laboratory biomarker analysis, pharmacological study - Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Central Nervous System Choriocarcinoma | Phase 1 | Terminated | National Cancer Institute (NCI) | 129 | 2010-03-01 | 2014-11-05 |
| Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors vorinostat, temozolomide, diagnostic laboratory biomarker analysis - Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Central Nervous System Choriocarcinoma | Phase 1 | Completed | National Cancer Institute (NCI) | 27 | 2010-02-01 | 2013-05-03 |
| Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma vorinostat, bortezomib, pharmacological study - Childhood Burkitt Lymphoma, Childhood Central Nervous System Choriocarcinoma | Phase 1 | Completed | National Cancer Institute (NCI) | 20 | 2009-08-01 | 2013-07-02 |
| ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors veliparib, temozolomide, pharmacological study - Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Central Nervous System Germ Cell Tumor | Phase 1 | Completed | National Cancer Institute (NCI) | 31 | 2009-07-01 | 2014-07-09 |
| Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment pazopanib hydrochloride, pharmacological study - Childhood Central Nervous System Choriocarcinoma, Childhood Central Nervous System Embryonal Tumor | Phase 1 | Completed | National Cancer Institute (NCI) | 55 | 2009-06-01 | 2013-09-30 |
| Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors carboplatin, dasatinib, etoposide phosphate - Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor | Phase 1 / Phase 2 | Terminated | City of Hope Medical Center | 7 | 2008-09-10 | 2026-11-04 |
Showing 20 of 58. Sign in to see all of them.
Optic Nerve Glioma (48) · Astrocytoma (46) · Medulloblastoma (43) · Familial ependymoma (40) · Oligodendroglioma (33) · Choroid Plexus Neoplasms (32) · Central Nervous System Neoplasms (30) · Neuroblastoma (15) · Neuroectodermal Tumors, Primitive, Peripheral (14) · Rhabdoid Tumor (14) · Sarcoma (12) · Spinal Cord Neoplasms (12) · Wilms Tumor (12) · Dendritic Cell Sarcoma, Interdigitating (11) · Recurrence (11)
Cranial Nerve Diseases (58) · Nervous System Diseases (58) · Neoplasms by Histologic Type (57) · Neoplasms, Nerve Tissue (57) · Neuroectodermal Tumors (57) · Neoplasms, Germ Cell and Embryonal (56) · Neoplasms (55) · Neoplasms by Site (55) · Nervous System Neoplasms (54) · Peripheral Nervous System Neoplasms (54) · Neoplasms, Glandular and Epithelial (50) · Eye Diseases (49) · Optic Nerve Diseases (49) · Optic Nerve Neoplasms (48)
Filgrastim (9) · Temozolomide (9) · Carboplatin (8) · Etoposide (4) · Granulocyte Colony-Stimulating Factor (4) · Bevacizumab (3) · Busulfan (3) · Ifosfamide (3) · Irinotecan (3) · O(6)-benzylguanine (3) · Peripheral Blood Stem Cell Transplantation (3) · 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (2) · Cyclophosphamide (2) · Melphalan (2) · Radiotherapy (2)
National Cancer Institute (NCI) (18) · Pediatric Brain Tumor Consortium (8) · Children's Oncology Group (6) · National Institutes of Health Clinical Center (CC) (3) · City of Hope Medical Center (2) · Beijing Tiantan Hospital (1) · Children's Cancer and Leukaemia Group (1) · Daiichi Sankyo (1) · Duke University (1) · Eli Lilly and Company (1) · FDA Office of Orphan Products Development (1) · Great Ormond Street Hospital for Children NHS Foundation Trust (1) · Harry T Whelan, MD (1) · Julie Krystal (1) · M.D. Anderson Cancer Center (1)
United States (52) · Canada (7) · Australia (2) · United Kingdom (2) · Austria (1) · China (1) · Ireland (1)
Elizabeth Fox, MD (2) · Mark W. Kieran, MD, PhD (2) · Susan M. Blaney, MD (2) · Aaron Tward, MD (1) · AeRang Kim, MD (1) · Allen R. Chen, MD, PhD, MHS (1) · Amar Gajjar (1) · Anna Pawlowska, MD (1) · Antonio Omuro (1) · Barbara Jean Bambach, MD (1) · Christoph Arnoldner (1) · D. Bradley Welling, MD, PhD (1) · Darren Hargrave, MB Bch (1) · Darren Hargrave, MD (1) · Denise Adams, MD (1)
PMID 15814645, PMID 16234526, PMID 16533779, PMID 16914576, PMID 17634493, PMID 17941066, PMID 18048828, PMID 18281544, PMID 18281546, PMID 19065567, PMID 19075272, PMID 19430790, PMID 20044751, PMID 20049936, PMID 20460632, PMID 21115653, PMID 21764821, PMID 23554030, PMID 23857966, PMID 26933802, PMID 37311055, PMID 41389341, PMID 9849694
U01CA081457 (9), U01CA097452 (8), P30CA008748 (1), P30CA033572 (1), U01CA069856 (1), UM1CA081457 (1)